EvolveImmune Therapeutics Holding Company, LLC — Form D
EvolveImmune Therapeutics Holding Company, LLC of Branford, CT, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-19. The offering totals $26.0M, of which $10.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-01-19
- Form: D
- Accession: 0001799828-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.0M
- Amount sold: $10.8M
- Remaining: $15.2M
- Investors: 8
- Date of first sale: 2023-01-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-471145
Issuer
- Name: EvolveImmune Therapeutics Holding Company, LLC
- CIK: 0001799828
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 23 Business Park Drive, Branford, CT, 06405
- Phone: 203-858-7389
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Donmienne Leung | Director | BOSTON, MA |
| Ian Taylor | Director | Madison, CT |
| Derek Yoon | Director | Boston, MA |
| Stephen Bloch | Director | Parsippany, NJ |
| Stephen Bloch | Executive Officer | Parsippany, NJ |
| Jasmina Marjanovic | Director | Cambridge, MA |
| Denis Patrick | Director | New City, NY |
| Alessandra Di Bacco | Director | Cambridge, MA |
| Hugo Beekman | Director | Boston, MA |
Other filings by this issuer (3)
More